These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36440189)

  • 21. [Continuing or stopping metformin in patients with type 2 diabetes exposed to SARS-CoV-2 ?].
    Scheen AJ; Paquot N
    Rev Med Liege; 2021 Mar; 76(3):152-155. PubMed ID: 33682382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Effect of Metformin Consumption on Mortality in Hospitalized COVID-19 patients: a systematic review and meta-analysis.
    Lukito AA; Pranata R; Henrina J; Lim MA; Lawrensia S; Suastika K
    Diabetes Metab Syndr; 2020; 14(6):2177-2183. PubMed ID: 33395778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Association Between Antidiabetic Agents and Clinical Outcomes of COVID-19 Patients With Diabetes: A Bayesian Network Meta-Analysis.
    Chen Y; Lv X; Lin S; Arshad M; Dai M
    Front Endocrinol (Lausanne); 2022; 13():895458. PubMed ID: 35692410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of metformin on mortality and severity in COVID-19 patients with diabetes mellitus.
    Yang W; Sun X; Zhang J; Zhang K
    Diabetes Res Clin Pract; 2021 Aug; 178():108977. PubMed ID: 34302912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The potential therapeutic effect of metformin in type 2 diabetic patients with severe COVID-19.
    Al-Kuraishy HM; Al-Gareeb AI; El Kholy AA; El-Khateeb E; Alexiou A; Papadakis M; Elekhnawy E; Alsubaie N; Hamad RS; Batiha GE
    Eur Rev Med Pharmacol Sci; 2023 Dec; 27(23):11445-11456. PubMed ID: 38095392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metformin and COVID-19: From cellular mechanisms to reduced mortality.
    Scheen AJ
    Diabetes Metab; 2020 Nov; 46(6):423-426. PubMed ID: 32750451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of Metformin in Patients With Type 2 Diabetes With COVID-19: A Preliminary Retrospective Report.
    Gao Y; Liu T; Zhong W; Liu R; Zhou H; Huang W; Zhang W
    Clin Transl Sci; 2020 Nov; 13(6):1055-1059. PubMed ID: 32955785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association Between Metformin Use and Mortality among Patients with Type 2 Diabetes Mellitus Hospitalized for COVID-19 Infection.
    Ong AN; Tan CC; Cañete MT; Lim BA; Robles J
    J ASEAN Fed Endocr Soc; 2021; 36(2):133-141. PubMed ID: 34966196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Vitamin B12 Deficiency in Type 2 Diabetes Mellitus].
    Tavares Bello C; Capitão RM; Sequeira Duarte J; Azinheira J; Vasconcelos C
    Acta Med Port; 2017 Oct; 30(10):719-726. PubMed ID: 29268066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin monotherapy for type 2 diabetes mellitus.
    Saenz A; Fernandez-Esteban I; Mataix A; Ausejo M; Roque M; Moher D
    Cochrane Database Syst Rev; 2005 Jul; (3):CD002966. PubMed ID: 16034881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of adverse in-hospital outcome and recovery in patients with diabetes mellitus and COVID-19 pneumonia in Iraq.
    Nafakhi H; Alareedh M; Al-Buthabhak K; Shaghee F; Nafakhi A; Kasim S
    Diabetes Metab Syndr; 2021; 15(1):33-38. PubMed ID: 33296788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
    Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; Brophy J; Afillalo J; Huynh T; Giannetti N; Bessissow A; Ezekowitz JA; Lopes RD; Ambrosy AP; Craig M; Sharma A
    Trials; 2021 Feb; 22(1):115. PubMed ID: 33546734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metformin use in patients hospitalized with COVID-19: lower inflammation, oxidative stress, and thrombotic risk markers and better clinical outcomes.
    Usman A; Bliden KP; Cho A; Walia N; Jerjian C; Singh A; Kundan P; Duhan S; Tantry US; Gurbel PA
    J Thromb Thrombolysis; 2022 Feb; 53(2):363-371. PubMed ID: 35041121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association Between Anti-diabetic Agents and Clinical Outcomes of COVID-19 in Patients with Diabetes: A Systematic Review and Meta-Analysis.
    Han T; Ma S; Sun C; Zhang H; Qu G; Chen Y; Cheng C; Chen EL; Ayaz Ahmed M; Kim KY; Manem R; Chen M; Guo Z; Yang H; Yan Y; Zhou Q
    Arch Med Res; 2022 Feb; 53(2):186-195. PubMed ID: 34412904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.
    Lancet; 1998 Sep; 352(9131):854-65. PubMed ID: 9742977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin and Covid-19: Focused Review of Mechanisms and Current Literature Suggesting Benefit.
    Ibrahim S; Lowe JR; Bramante CT; Shah S; Klatt NR; Sherwood N; Aronne L; Puskarich M; Tamariz L; Palacio A; Bomberg E; Usher M; King S; Benson B; Vojta D; Tignanelli C; Ingraham N
    Front Endocrinol (Lausanne); 2021; 12():587801. PubMed ID: 34367059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Type 2 diabetes and metformin. First choice for monotherapy: weak evidence of efficacy but well-known and acceptable adverse effects.
    Prescrire Int; 2014 Nov; 23(154):269-72. PubMed ID: 25954799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Long-term Effects of Metformin on Patients With Type 2 Diabetic Kidney Disease.
    Kwon S; Kim YC; Park JY; Lee J; An JN; Kim CT; Oh S; Park S; Kim DK; Oh YK; Kim YS; Lim CS; Lee JP
    Diabetes Care; 2020 May; 43(5):948-955. PubMed ID: 32132005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metformin in SARS-CoV-2 infection: A hidden path - from altered inflammation to reduced mortality. A review from the literature.
    Pedrosa AR; Martins DC; Rizzo M; Silva-Nunes J
    J Diabetes Complications; 2023 Feb; 37(2):108391. PubMed ID: 36621213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.